nodes	percent_of_prediction	percent_of_DWPC	metapath
Moclobemide—CYP2C19—Prednisone—ankylosing spondylitis	0.0446	0.382	CbGbCtD
Moclobemide—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0279	0.239	CbGbCtD
Moclobemide—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0232	0.198	CbGbCtD
Moclobemide—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0212	0.181	CbGbCtD
Moclobemide—Osteoarthritis—Dexamethasone—ankylosing spondylitis	0.00527	0.00596	CcSEcCtD
Moclobemide—Osteoarthritis—Betamethasone—ankylosing spondylitis	0.00527	0.00596	CcSEcCtD
Moclobemide—Migraine—Dexamethasone—ankylosing spondylitis	0.00518	0.00587	CcSEcCtD
Moclobemide—Migraine—Betamethasone—ankylosing spondylitis	0.00518	0.00587	CcSEcCtD
Moclobemide—Abdominal distension—Triamcinolone—ankylosing spondylitis	0.00505	0.00572	CcSEcCtD
Moclobemide—Abdominal distension—Methylprednisolone—ankylosing spondylitis	0.00504	0.0057	CcSEcCtD
Moclobemide—Irritability—Dexamethasone—ankylosing spondylitis	0.00503	0.00569	CcSEcCtD
Moclobemide—Irritability—Betamethasone—ankylosing spondylitis	0.00503	0.00569	CcSEcCtD
Moclobemide—Dry skin—Betamethasone—ankylosing spondylitis	0.00483	0.00546	CcSEcCtD
Moclobemide—Dry skin—Dexamethasone—ankylosing spondylitis	0.00483	0.00546	CcSEcCtD
Moclobemide—Urine output increased—Methotrexate—ankylosing spondylitis	0.00477	0.0054	CcSEcCtD
Moclobemide—Conjunctivitis—Prednisolone—ankylosing spondylitis	0.00473	0.00535	CcSEcCtD
Moclobemide—Osteoarthritis—Prednisone—ankylosing spondylitis	0.00459	0.00519	CcSEcCtD
Moclobemide—Bradycardia—Prednisolone—ankylosing spondylitis	0.00444	0.00503	CcSEcCtD
Moclobemide—Irritability—Prednisone—ankylosing spondylitis	0.00438	0.00496	CcSEcCtD
Moclobemide—Polyuria—Methotrexate—ankylosing spondylitis	0.00436	0.00494	CcSEcCtD
Moclobemide—Conjunctivitis—Triamcinolone—ankylosing spondylitis	0.00435	0.00492	CcSEcCtD
Moclobemide—Sweating—Methylprednisolone—ankylosing spondylitis	0.00428	0.00484	CcSEcCtD
Moclobemide—Visual impairment—Prednisolone—ankylosing spondylitis	0.00421	0.00476	CcSEcCtD
Moclobemide—Dry skin—Prednisone—ankylosing spondylitis	0.0042	0.00476	CcSEcCtD
Moclobemide—Bradycardia—Triamcinolone—ankylosing spondylitis	0.00409	0.00463	CcSEcCtD
Moclobemide—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.00408	0.00462	CcSEcCtD
Moclobemide—Visual disturbance—Methotrexate—ankylosing spondylitis	0.00404	0.00458	CcSEcCtD
Moclobemide—Abdominal distension—Prednisone—ankylosing spondylitis	0.00399	0.00452	CcSEcCtD
Moclobemide—Hallucination—Methylprednisolone—ankylosing spondylitis	0.00399	0.00451	CcSEcCtD
Moclobemide—Conjunctivitis—Dexamethasone—ankylosing spondylitis	0.00394	0.00447	CcSEcCtD
Moclobemide—Conjunctivitis—Betamethasone—ankylosing spondylitis	0.00394	0.00447	CcSEcCtD
Moclobemide—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.00386	0.00437	CcSEcCtD
Moclobemide—Osteoarthritis—Methotrexate—ankylosing spondylitis	0.00383	0.00434	CcSEcCtD
Moclobemide—Bradycardia—Betamethasone—ankylosing spondylitis	0.00371	0.0042	CcSEcCtD
Moclobemide—Bradycardia—Dexamethasone—ankylosing spondylitis	0.00371	0.0042	CcSEcCtD
Moclobemide—Irritability—Methotrexate—ankylosing spondylitis	0.00366	0.00414	CcSEcCtD
Moclobemide—Hallucination—Betamethasone—ankylosing spondylitis	0.00362	0.0041	CcSEcCtD
Moclobemide—Hallucination—Dexamethasone—ankylosing spondylitis	0.00362	0.0041	CcSEcCtD
Moclobemide—Vision blurred—Prednisolone—ankylosing spondylitis	0.00358	0.00406	CcSEcCtD
Moclobemide—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.00353	0.00399	CcSEcCtD
Moclobemide—Visual impairment—Dexamethasone—ankylosing spondylitis	0.00351	0.00397	CcSEcCtD
Moclobemide—Visual impairment—Betamethasone—ankylosing spondylitis	0.00351	0.00397	CcSEcCtD
Moclobemide—Malaise—Prednisolone—ankylosing spondylitis	0.00343	0.00388	CcSEcCtD
Moclobemide—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.00342	0.00388	CcSEcCtD
Moclobemide—Syncope—Prednisolone—ankylosing spondylitis	0.00341	0.00386	CcSEcCtD
Moclobemide—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00334	0.00378	CcSEcCtD
Moclobemide—Hypertension—Prednisolone—ankylosing spondylitis	0.00328	0.00372	CcSEcCtD
Moclobemide—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.00324	0.00367	CcSEcCtD
Moclobemide—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.00324	0.00366	CcSEcCtD
Moclobemide—Bradycardia—Prednisone—ankylosing spondylitis	0.00323	0.00366	CcSEcCtD
Moclobemide—Discomfort—Prednisolone—ankylosing spondylitis	0.0032	0.00362	CcSEcCtD
Moclobemide—Hallucination—Prednisone—ankylosing spondylitis	0.00316	0.00357	CcSEcCtD
Moclobemide—Malaise—Triamcinolone—ankylosing spondylitis	0.00315	0.00357	CcSEcCtD
Moclobemide—Malaise—Methylprednisolone—ankylosing spondylitis	0.00314	0.00356	CcSEcCtD
Moclobemide—Syncope—Triamcinolone—ankylosing spondylitis	0.00313	0.00355	CcSEcCtD
Moclobemide—Syncope—Methylprednisolone—ankylosing spondylitis	0.00313	0.00354	CcSEcCtD
Moclobemide—Dysuria—Methotrexate—ankylosing spondylitis	0.0031	0.00351	CcSEcCtD
Moclobemide—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00307	0.00348	CcSEcCtD
Moclobemide—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00306	0.00347	CcSEcCtD
Moclobemide—Shock—Prednisolone—ankylosing spondylitis	0.00305	0.00346	CcSEcCtD
Moclobemide—Tachycardia—Prednisolone—ankylosing spondylitis	0.00303	0.00343	CcSEcCtD
Moclobemide—Hypertension—Triamcinolone—ankylosing spondylitis	0.00302	0.00342	CcSEcCtD
Moclobemide—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00301	0.00341	CcSEcCtD
Moclobemide—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.003	0.00339	CcSEcCtD
Moclobemide—Myalgia—Triamcinolone—ankylosing spondylitis	0.00298	0.00337	CcSEcCtD
Moclobemide—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00297	0.00336	CcSEcCtD
Moclobemide—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00296	0.00335	CcSEcCtD
Moclobemide—Drowsiness—Methotrexate—ankylosing spondylitis	0.00295	0.00334	CcSEcCtD
Moclobemide—Flushing—Prednisone—ankylosing spondylitis	0.00294	0.00333	CcSEcCtD
Moclobemide—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00294	0.00333	CcSEcCtD
Moclobemide—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00294	0.00333	CcSEcCtD
Moclobemide—Discomfort—Triamcinolone—ankylosing spondylitis	0.00294	0.00333	CcSEcCtD
Moclobemide—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00293	0.00332	CcSEcCtD
Moclobemide—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00291	0.00329	CcSEcCtD
Moclobemide—Stomatitis—Methotrexate—ankylosing spondylitis	0.00288	0.00326	CcSEcCtD
Moclobemide—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.00287	0.00325	CcSEcCtD
Moclobemide—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00287	0.00325	CcSEcCtD
Moclobemide—Malaise—Betamethasone—ankylosing spondylitis	0.00286	0.00324	CcSEcCtD
Moclobemide—Malaise—Dexamethasone—ankylosing spondylitis	0.00286	0.00324	CcSEcCtD
Moclobemide—Syncope—Dexamethasone—ankylosing spondylitis	0.00284	0.00322	CcSEcCtD
Moclobemide—Syncope—Betamethasone—ankylosing spondylitis	0.00284	0.00322	CcSEcCtD
Moclobemide—Sweating—Methotrexate—ankylosing spondylitis	0.00283	0.00321	CcSEcCtD
Moclobemide—Shock—Triamcinolone—ankylosing spondylitis	0.00281	0.00318	CcSEcCtD
Moclobemide—Insomnia—Prednisolone—ankylosing spondylitis	0.00281	0.00318	CcSEcCtD
Moclobemide—Shock—Methylprednisolone—ankylosing spondylitis	0.0028	0.00317	CcSEcCtD
Moclobemide—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00279	0.00316	CcSEcCtD
Moclobemide—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00279	0.00316	CcSEcCtD
Moclobemide—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00278	0.00315	CcSEcCtD
Moclobemide—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00278	0.00315	CcSEcCtD
Moclobemide—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00278	0.00314	CcSEcCtD
Moclobemide—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00276	0.00312	CcSEcCtD
Moclobemide—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00275	0.00312	CcSEcCtD
Moclobemide—Hypertension—Dexamethasone—ankylosing spondylitis	0.00274	0.0031	CcSEcCtD
Moclobemide—Hypertension—Betamethasone—ankylosing spondylitis	0.00274	0.0031	CcSEcCtD
Moclobemide—Myalgia—Dexamethasone—ankylosing spondylitis	0.0027	0.00306	CcSEcCtD
Moclobemide—Myalgia—Betamethasone—ankylosing spondylitis	0.0027	0.00306	CcSEcCtD
Moclobemide—Anxiety—Dexamethasone—ankylosing spondylitis	0.00269	0.00305	CcSEcCtD
Moclobemide—Anxiety—Betamethasone—ankylosing spondylitis	0.00269	0.00305	CcSEcCtD
Moclobemide—Discomfort—Betamethasone—ankylosing spondylitis	0.00267	0.00302	CcSEcCtD
Moclobemide—Discomfort—Dexamethasone—ankylosing spondylitis	0.00267	0.00302	CcSEcCtD
Moclobemide—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00266	0.00301	CcSEcCtD
Moclobemide—Vision blurred—Prednisone—ankylosing spondylitis	0.0026	0.00295	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.0026	0.00294	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00259	0.00294	CcSEcCtD
Moclobemide—Insomnia—Triamcinolone—ankylosing spondylitis	0.00258	0.00292	CcSEcCtD
Moclobemide—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00257	0.00291	CcSEcCtD
Moclobemide—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00256	0.0029	CcSEcCtD
Moclobemide—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00256	0.0029	CcSEcCtD
Moclobemide—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00256	0.00289	CcSEcCtD
Moclobemide—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00256	0.00289	CcSEcCtD
Moclobemide—Visual impairment—Methotrexate—ankylosing spondylitis	0.00255	0.00289	CcSEcCtD
Moclobemide—Shock—Dexamethasone—ankylosing spondylitis	0.00255	0.00288	CcSEcCtD
Moclobemide—Shock—Betamethasone—ankylosing spondylitis	0.00255	0.00288	CcSEcCtD
Moclobemide—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00254	0.00288	CcSEcCtD
Moclobemide—Agitation—Prednisone—ankylosing spondylitis	0.00254	0.00287	CcSEcCtD
Moclobemide—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00253	0.00286	CcSEcCtD
Moclobemide—Tachycardia—Betamethasone—ankylosing spondylitis	0.00253	0.00286	CcSEcCtD
Moclobemide—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00251	0.00284	CcSEcCtD
Moclobemide—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00251	0.00284	CcSEcCtD
Moclobemide—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.0025	0.00283	CcSEcCtD
Moclobemide—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.0025	0.00283	CcSEcCtD
Moclobemide—Malaise—Prednisone—ankylosing spondylitis	0.00249	0.00282	CcSEcCtD
Moclobemide—Syncope—Prednisone—ankylosing spondylitis	0.00248	0.0028	CcSEcCtD
Moclobemide—Tinnitus—Methotrexate—ankylosing spondylitis	0.00247	0.0028	CcSEcCtD
Moclobemide—Urticaria—Prednisolone—ankylosing spondylitis	0.00246	0.00279	CcSEcCtD
Moclobemide—Fatigue—Triamcinolone—ankylosing spondylitis	0.00246	0.00278	CcSEcCtD
Moclobemide—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00245	0.00278	CcSEcCtD
Moclobemide—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00243	0.00275	CcSEcCtD
Moclobemide—Hypotension—Betamethasone—ankylosing spondylitis	0.00242	0.00274	CcSEcCtD
Moclobemide—Hypotension—Dexamethasone—ankylosing spondylitis	0.00242	0.00274	CcSEcCtD
Moclobemide—Hypertension—Prednisone—ankylosing spondylitis	0.00238	0.0027	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00236	0.00267	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00236	0.00267	CcSEcCtD
Moclobemide—Myalgia—Prednisone—ankylosing spondylitis	0.00235	0.00266	CcSEcCtD
Moclobemide—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00235	0.00266	CcSEcCtD
Moclobemide—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00235	0.00266	CcSEcCtD
Moclobemide—Anxiety—Prednisone—ankylosing spondylitis	0.00234	0.00265	CcSEcCtD
Moclobemide—Insomnia—Betamethasone—ankylosing spondylitis	0.00234	0.00265	CcSEcCtD
Moclobemide—Insomnia—Dexamethasone—ankylosing spondylitis	0.00234	0.00265	CcSEcCtD
Moclobemide—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00233	0.00263	CcSEcCtD
Moclobemide—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00232	0.00263	CcSEcCtD
Moclobemide—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00232	0.00263	CcSEcCtD
Moclobemide—Discomfort—Prednisone—ankylosing spondylitis	0.00232	0.00263	CcSEcCtD
Moclobemide—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00228	0.00258	CcSEcCtD
Moclobemide—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00228	0.00258	CcSEcCtD
Moclobemide—Urticaria—Triamcinolone—ankylosing spondylitis	0.00227	0.00257	CcSEcCtD
Moclobemide—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00226	0.00256	CcSEcCtD
Moclobemide—Dysgeusia—Methotrexate—ankylosing spondylitis	0.00226	0.00256	CcSEcCtD
Moclobemide—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00225	0.00255	CcSEcCtD
Moclobemide—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00225	0.00255	CcSEcCtD
Moclobemide—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00225	0.00255	CcSEcCtD
Moclobemide—Fatigue—Betamethasone—ankylosing spondylitis	0.00223	0.00253	CcSEcCtD
Moclobemide—Fatigue—Dexamethasone—ankylosing spondylitis	0.00223	0.00253	CcSEcCtD
Moclobemide—Shock—Prednisone—ankylosing spondylitis	0.00222	0.00251	CcSEcCtD
Moclobemide—Tachycardia—Prednisone—ankylosing spondylitis	0.0022	0.00249	CcSEcCtD
Moclobemide—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00218	0.00247	CcSEcCtD
Moclobemide—Vision blurred—Methotrexate—ankylosing spondylitis	0.00217	0.00246	CcSEcCtD
Moclobemide—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.00214	0.00242	CcSEcCtD
Moclobemide—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00213	0.00241	CcSEcCtD
Moclobemide—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00213	0.00241	CcSEcCtD
Moclobemide—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00212	0.0024	CcSEcCtD
Moclobemide—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00212	0.0024	CcSEcCtD
Moclobemide—Malaise—Methotrexate—ankylosing spondylitis	0.00208	0.00236	CcSEcCtD
Moclobemide—Urticaria—Dexamethasone—ankylosing spondylitis	0.00206	0.00233	CcSEcCtD
Moclobemide—Urticaria—Betamethasone—ankylosing spondylitis	0.00206	0.00233	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00205	0.00232	CcSEcCtD
Moclobemide—Dizziness—Prednisolone—ankylosing spondylitis	0.00205	0.00232	CcSEcCtD
Moclobemide—Asthenia—Triamcinolone—ankylosing spondylitis	0.00205	0.00232	CcSEcCtD
Moclobemide—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00205	0.00232	CcSEcCtD
Moclobemide—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00205	0.00232	CcSEcCtD
Moclobemide—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00204	0.00231	CcSEcCtD
Moclobemide—Insomnia—Prednisone—ankylosing spondylitis	0.00204	0.00231	CcSEcCtD
Moclobemide—Paraesthesia—Prednisone—ankylosing spondylitis	0.00202	0.00229	CcSEcCtD
Moclobemide—Pruritus—Triamcinolone—ankylosing spondylitis	0.00202	0.00228	CcSEcCtD
Moclobemide—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00201	0.00228	CcSEcCtD
Moclobemide—Dyspepsia—Prednisone—ankylosing spondylitis	0.00198	0.00225	CcSEcCtD
Moclobemide—Chest pain—Methotrexate—ankylosing spondylitis	0.00196	0.00222	CcSEcCtD
Moclobemide—Myalgia—Methotrexate—ankylosing spondylitis	0.00196	0.00222	CcSEcCtD
Moclobemide—Decreased appetite—Prednisone—ankylosing spondylitis	0.00196	0.00222	CcSEcCtD
Moclobemide—Rash—Prednisolone—ankylosing spondylitis	0.00196	0.00221	CcSEcCtD
Moclobemide—Dermatitis—Prednisolone—ankylosing spondylitis	0.00195	0.00221	CcSEcCtD
Moclobemide—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00195	0.0022	CcSEcCtD
Moclobemide—Fatigue—Prednisone—ankylosing spondylitis	0.00194	0.0022	CcSEcCtD
Moclobemide—Headache—Prednisolone—ankylosing spondylitis	0.00194	0.0022	CcSEcCtD
Moclobemide—Discomfort—Methotrexate—ankylosing spondylitis	0.00194	0.0022	CcSEcCtD
Moclobemide—Constipation—Prednisone—ankylosing spondylitis	0.00193	0.00218	CcSEcCtD
Moclobemide—Confusional state—Methotrexate—ankylosing spondylitis	0.0019	0.00215	CcSEcCtD
Moclobemide—Dizziness—Triamcinolone—ankylosing spondylitis	0.00189	0.00214	CcSEcCtD
Moclobemide—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00188	0.00213	CcSEcCtD
Moclobemide—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00186	0.0021	CcSEcCtD
Moclobemide—Asthenia—Betamethasone—ankylosing spondylitis	0.00186	0.0021	CcSEcCtD
Moclobemide—Asthenia—Dexamethasone—ankylosing spondylitis	0.00186	0.0021	CcSEcCtD
Moclobemide—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00184	0.00209	CcSEcCtD
Moclobemide—Nausea—Prednisolone—ankylosing spondylitis	0.00184	0.00209	CcSEcCtD
Moclobemide—Pruritus—Betamethasone—ankylosing spondylitis	0.00183	0.00207	CcSEcCtD
Moclobemide—Pruritus—Dexamethasone—ankylosing spondylitis	0.00183	0.00207	CcSEcCtD
Moclobemide—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00182	0.00206	CcSEcCtD
Moclobemide—Vomiting—Triamcinolone—ankylosing spondylitis	0.00181	0.00205	CcSEcCtD
Moclobemide—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00181	0.00205	CcSEcCtD
Moclobemide—Rash—Triamcinolone—ankylosing spondylitis	0.0018	0.00204	CcSEcCtD
Moclobemide—Dermatitis—Triamcinolone—ankylosing spondylitis	0.0018	0.00203	CcSEcCtD
Moclobemide—Rash—Methylprednisolone—ankylosing spondylitis	0.00179	0.00203	CcSEcCtD
Moclobemide—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00179	0.00203	CcSEcCtD
Moclobemide—Urticaria—Prednisone—ankylosing spondylitis	0.00179	0.00203	CcSEcCtD
Moclobemide—Headache—Triamcinolone—ankylosing spondylitis	0.00179	0.00202	CcSEcCtD
Moclobemide—Headache—Methylprednisolone—ankylosing spondylitis	0.00178	0.00202	CcSEcCtD
Moclobemide—Abdominal pain—Prednisone—ankylosing spondylitis	0.00178	0.00202	CcSEcCtD
Moclobemide—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00177	0.002	CcSEcCtD
Moclobemide—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00177	0.002	CcSEcCtD
Moclobemide—Hypotension—Methotrexate—ankylosing spondylitis	0.00176	0.00199	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00172	0.00194	CcSEcCtD
Moclobemide—Dizziness—Dexamethasone—ankylosing spondylitis	0.00171	0.00194	CcSEcCtD
Moclobemide—Dizziness—Betamethasone—ankylosing spondylitis	0.00171	0.00194	CcSEcCtD
Moclobemide—Insomnia—Methotrexate—ankylosing spondylitis	0.0017	0.00193	CcSEcCtD
Moclobemide—Nausea—Triamcinolone—ankylosing spondylitis	0.00169	0.00192	CcSEcCtD
Moclobemide—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00169	0.00192	CcSEcCtD
Moclobemide—Nausea—Methylprednisolone—ankylosing spondylitis	0.00169	0.00191	CcSEcCtD
Moclobemide—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00168	0.0019	CcSEcCtD
Moclobemide—Somnolence—Methotrexate—ankylosing spondylitis	0.00167	0.0019	CcSEcCtD
Moclobemide—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00166	0.00188	CcSEcCtD
Moclobemide—Vomiting—Betamethasone—ankylosing spondylitis	0.00165	0.00186	CcSEcCtD
Moclobemide—Vomiting—Dexamethasone—ankylosing spondylitis	0.00165	0.00186	CcSEcCtD
Moclobemide—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00164	0.00185	CcSEcCtD
Moclobemide—Rash—Dexamethasone—ankylosing spondylitis	0.00163	0.00185	CcSEcCtD
Moclobemide—Rash—Betamethasone—ankylosing spondylitis	0.00163	0.00185	CcSEcCtD
Moclobemide—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00163	0.00185	CcSEcCtD
Moclobemide—Dermatitis—Betamethasone—ankylosing spondylitis	0.00163	0.00185	CcSEcCtD
Moclobemide—Fatigue—Methotrexate—ankylosing spondylitis	0.00162	0.00184	CcSEcCtD
Moclobemide—Headache—Betamethasone—ankylosing spondylitis	0.00162	0.00184	CcSEcCtD
Moclobemide—Headache—Dexamethasone—ankylosing spondylitis	0.00162	0.00184	CcSEcCtD
Moclobemide—Asthenia—Prednisone—ankylosing spondylitis	0.00162	0.00183	CcSEcCtD
Moclobemide—Pruritus—Prednisone—ankylosing spondylitis	0.00159	0.00181	CcSEcCtD
Moclobemide—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00155	0.00176	CcSEcCtD
Moclobemide—Diarrhoea—Prednisone—ankylosing spondylitis	0.00154	0.00175	CcSEcCtD
Moclobemide—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00154	0.00174	CcSEcCtD
Moclobemide—Nausea—Dexamethasone—ankylosing spondylitis	0.00154	0.00174	CcSEcCtD
Moclobemide—Nausea—Betamethasone—ankylosing spondylitis	0.00154	0.00174	CcSEcCtD
Moclobemide—Urticaria—Methotrexate—ankylosing spondylitis	0.0015	0.00169	CcSEcCtD
Moclobemide—Dizziness—Prednisone—ankylosing spondylitis	0.00149	0.00169	CcSEcCtD
Moclobemide—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00149	0.00169	CcSEcCtD
Moclobemide—Vomiting—Prednisone—ankylosing spondylitis	0.00143	0.00162	CcSEcCtD
Moclobemide—Rash—Prednisone—ankylosing spondylitis	0.00142	0.00161	CcSEcCtD
Moclobemide—Dermatitis—Prednisone—ankylosing spondylitis	0.00142	0.00161	CcSEcCtD
Moclobemide—Headache—Prednisone—ankylosing spondylitis	0.00141	0.0016	CcSEcCtD
Moclobemide—Asthenia—Methotrexate—ankylosing spondylitis	0.00135	0.00153	CcSEcCtD
Moclobemide—Nausea—Prednisone—ankylosing spondylitis	0.00134	0.00152	CcSEcCtD
Moclobemide—Pruritus—Methotrexate—ankylosing spondylitis	0.00133	0.00151	CcSEcCtD
Moclobemide—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00129	0.00146	CcSEcCtD
Moclobemide—Dizziness—Methotrexate—ankylosing spondylitis	0.00125	0.00141	CcSEcCtD
Moclobemide—Vomiting—Methotrexate—ankylosing spondylitis	0.0012	0.00136	CcSEcCtD
Moclobemide—Rash—Methotrexate—ankylosing spondylitis	0.00119	0.00134	CcSEcCtD
Moclobemide—Dermatitis—Methotrexate—ankylosing spondylitis	0.00119	0.00134	CcSEcCtD
Moclobemide—Headache—Methotrexate—ankylosing spondylitis	0.00118	0.00134	CcSEcCtD
Moclobemide—Nausea—Methotrexate—ankylosing spondylitis	0.00112	0.00127	CcSEcCtD
